Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on INT 1. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN120794983A reveals low-cost copper catalysis for Upadacitinib intermediates. Achieve significant cost reduction and supply chain reliability.
Novel preparation method for avibactam intermediate ensures high purity and cost efficiency. Ideal for reliable pharmaceutical intermediates supplier partnerships.
Discover the novel trityl-protected synthesis route for Bempedoic Acid intermediates described in CN115611739A. Achieve higher purity, safer operations, and scalable manufacturing for cardiovascular APIs.
Patent CN105622413B details a novel route for posaconazole intermediates offering cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN117417285B reveals metal-free route for Evocalcet intermediates offering cost reduction and supply chain reliability for pharmaceutical manufacturing partners globally
Novel patent CN119060034A offers high-yield morpholine synthesis without chiral resolution ensuring cost-effective and reliable supply chain solutions for global pharmaceutical manufacturers.
Novel synthesis method for Upadacitinib intermediate ensures high optical purity and scalable production for pharmaceutical supply chains globally.
Advanced preparation of 5-chloroacetamide-N,N'-bi(2,3-dihydroxyl propyl)-2,4,6-triiodo-1,3-benzenedicarboxamide via optimized acyl chloride pathway for cost-effective contrast media manufacturing.
Patent CN103242215A details a safer transfer hydrogenation route for Lenalidomide intermediates, offering significant cost reduction and simplified supply chain management for pharmaceutical manufacturers.
Patent CN114032258B reveals enzymatic route for L-butylphthalide intermediate. Offers high purity and cost efficiency for pharmaceutical supply chains.
Patent CN105237569A reveals improved iodine-catalyzed synthesis. Delivers higher yield and simplified processing for reliable pharmaceutical intermediate supply chains.
Novel acidified silica gel method for dabigatran intermediate. Reduces waste, improves purity, ensures supply chain stability for pharma manufacturing.
Patent CN101974604B details a novel ionic liquid biocatalysis route for paroxetine intermediates, offering high optical purity and reduced environmental impact for reliable supply chains.
Novel salt formation method ensures over 99 percent purity for Perampanel intermediate. Reduces impurities significantly for reliable pharmaceutical intermediate supply chains.
Patent CN101974604A reveals a green enzymatic route for paroxetine intermediates using ionic liquids, offering high purity and reduced environmental impact for API manufacturing.
Novel dehalogenase method for pitavastatin intermediates offers high purity and yield. Reduces environmental impact and enhances supply chain reliability for pharmaceutical manufacturers globally.
Novel catalyst-free route for Tadalafil intermediate ensures high purity and supply stability for global pharmaceutical manufacturing partners seeking reliable scale-up.
Novel safe route for Tedizolid intermediate avoids azides. Reduces impurities and enhances supply chain reliability for pharmaceutical manufacturing.
Novel synthesis of Aliskiren intermediate via etherification and enzymatic resolution. Reduces steps and cost for API manufacturing significantly.
Patent CN111892547A details a low-salt synthesis for prothioconazole intermediates. Discover cost-effective manufacturing and scalable supply chain solutions.